Author

Lynsey A. Melville

Observed name: Lynsey Melville

Institutions: Centre for Inflammation Research, University of Edinburgh

Observed institutions: Centre for Inflammation Research, The Queen's Medical Research Institute, Medical Research Council, University of Edinburgh

OpenAlex ID: A5020177041

CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis

2008 · Lucy A. Truman, Catriona A. Ford, et al. · Blood · 503

Apoptotic human cells inhibit migration of granulocytes via release of lactoferrin

2008 · Irini Bournazou, John D. Pound, et al. · Journal of Clinical Investigation · 221

Persistence of apoptotic cells without autoimmune disease or inflammation in CD14−/− mice

2004 · Andrew Devitt, Kate G. Parker, et al. · The Journal of Cell Biology · 137

Oncogenic Properties of Apoptotic Tumor Cells in Aggressive B Cell Lymphoma

2015 · Catriona A. Ford, Sofia Petrova, et al. · Current Biology · 133

Modulation of macrophage antitumor potential by apoptotic lymphoma cells

2017 · Jorine J L P Voss, Catriona A Ford, et al. · Cell Death and Differentiation · 66

Potential Oncogenic Effect of the MERTK-Dependent Apoptotic-Cell Clearance Pathway in Starry-Sky B-Cell Lymphoma

2020 · Sarah Farnworth-McHugh, Nicole Barth, et al. · Frontiers in Immunology · 12

macrophage chemotaxis CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate

2013 · Christophe Combadière, Christopher D. Gregory, et al.

Works count: 7

Citation count: 1,072

H-index: 6

I10-index: 6